Friday, 3 January 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 03 January 2025
News

Meet the new blockbusters

Posted 6 February 2023 AM

A new wave of potential blockbusters has emerged with eight of the top 15 contenders either already approved in Australia or currently under the TGA's evaluation.

A curated list of drugs anticipated to become 'the next big thing' has been compiled by Clarivate in its 2023 Drugs to Watch report. They are forecast to deliver annual sales of more than US$1 billion in the next five years or transform paradigms to meet unmet patient needs.

To see the whole article, please login

Popular

Who got booted to the May meet?
Company tops Rotten Tomato list
Best company Christmas gift is...
First out the door in '25?
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home